You are here

Article Text

Article menu
Download PDFPDF
LETTER
Nasal nitric oxide to diagnose primary ciliary dyskinesia in newborns
  1. F Stehling,
  2. C Roll,
  3. F Ratjen,
  4. H Grasemann
  1. Children’s Hospital, University of Duisburg-Essen, Essen, Germany
  1. Correspondence to:
    Dr Grasemann
    The Hospital for Sick Children, Division of Respiratory Medicine, 555 University Ave, Toronto, Ontario, Canada M5G 1XA; hartmut.grasemann{at}sickkids.ca

https://doi.org/10.1136/adc.2005.086702

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Retrospective data suggest that approximately half of patients with primary ciliary dyskinesia (PCD) have symptoms of neonatal respiratory distress. Respiratory distress syndrome in a full term infant should therefore raise PCD as a potential underlying disease.1,2 The non-invasive measurement of nasal nitric oxide (NO) is of diagnostic value in adults and children with PCD,1,3 but similar information is not available for neonates with PCD.

    A 3550 g male infant was delivered after uncomplicated …

    View Full Text

    Footnotes

    • Competing interests: none declared